WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr | ₹7,376 Cr | ₹7,749 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹7,070 Cr |
Mar2023 | ₹7,075 Cr |
Mar2022 | ₹7,670 Cr |
Mar2021 | ₹7,376 Cr |
Mar2020 | ₹7,749 Cr |
How is Total Liabilities of WOCKHARDT Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹7,070 Cr | -0.07 | |
Mar2023 | ₹7,075 Cr | -7.76 | |
Mar2022 | ₹7,670 Cr | 3.99 | |
Mar2021 | ₹7,376 Cr | -4.82 | |
Mar2020 | ₹7,749 Cr | - |
Compare Total Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹26,040.6 Cr | 1.9% | 15.5% | 262.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 1.9% |
15.5% |
262.3% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses